Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

PHASE2RecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

March 21, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2032

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Arlocabtagene Autoleucel

Specified dose on specified days

Trial Locations (52)

2050

RECRUITING

Royal Prince Alfred Hospital, Camperdown

3004

NOT_YET_RECRUITING

Local Institution - 0074, Melbourne

3065

NOT_YET_RECRUITING

Local Institution - 0076, Melbourne

4029

NOT_YET_RECRUITING

Local Institution - 0075, Brisbane

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

19107

NOT_YET_RECRUITING

Local Institution - 0070, Philadelphia

21218

WITHDRAWN

Local Institution - 0065, Baltimore

23502

RECRUITING

Virginia Oncology Associates, Norfolk

27599

RECRUITING

University of North Carolina Medical Center, Chapel Hill

28204

WITHDRAWN

Local Institution - 0067, Charlotte

30322

RECRUITING

Winship Cancer Institute of Emory University, Atlanta

30342

RECRUITING

Northside Hospital, Atlanta

32224

RECRUITING

Mayo Clinic in Florida, Jacksonville

33176

RECRUITING

Miami Cancer Institute at Baptist Health, Inc., Miami

33612

RECRUITING

Moffitt Cancer Center, Tampa

37203

RECRUITING

Tennessee Oncology, Nashville

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

40207

RECRUITING

Norton Women's and Children's Hospital, Louisville

43210

RECRUITING

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus

45242

RECRUITING

Oncology Hematology Care, Cincinnati

52242

RECRUITING

University of Iowa, Iowa City

53792

RECRUITING

University Hospital and UW Health Clinics, Madison

55905

RECRUITING

Mayo Clinic in Rochester, Minnesota, Rochester

60611

RECRUITING

Northwestern Memorial Hospital, Chicago

60637

RECRUITING

University of Chicago Medical Center, Chicago

63110

RECRUITING

Washington University School of Medicine, St Louis

66205

RECRUITING

The University of Kansas Cancer Center - Westwood, Westwood

72205

RECRUITING

University of Arkansas for Medical Sciences, Little Rock

75390

RECRUITING

UT Southwestern Medical Center, Dallas

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

78229

RECRUITING

Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio

78704

WITHDRAWN

Local Institution - 0069, Austin

80218

RECRUITING

Colorado Blood Cancer Institute, Denver

84143

RECRUITING

LDS Hospital, Salt Lake City

85234

RECRUITING

Banner MD Anderson Cancer Center, Gilbert

90095

RECRUITING

UCLA Hematology/Oncology - Westwood (Building 200 Suite 214), Los Angeles

94143

RECRUITING

UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco

97239

RECRUITING

Oregon Health and Science University, Portland

98109

RECRUITING

Fred Hutchinson Cancer Center, Seattle

35294-3300

RECRUITING

University of Alabama at Birmingham, Birmingham

02114

RECRUITING

Massachusetts General Hospital, Boston

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

T2N 4N2

RECRUITING

Tom Baker Cancer Center, Calgary

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

467-8602

RECRUITING

Nagoya City University Hospital, Nagoya

663-8501

RECRUITING

Hyogo Medical University Hospital, Nishinomiya

260-8677

RECRUITING

Chiba University Hospital, Chiba

602-8566

RECRUITING

University Hospital,Kyoto Prefectural University of Medicine, Kyoto

150-8935

RECRUITING

Japanese Red Cross Medical Center, Tokyo

All Listed Sponsors
lead

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

INDUSTRY